E
NMRD

Ergoteles’s Nemaura Medical, Inc. Common Stock NMRD Stock Holding History

Ergoteles’s Portfolio NMRD Stock Details NMRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-28,800
Closed -$298K – 1796
2021
Q2 		$298K Buy
+28,800
New +$275K 0.01% 1068

Other funds holding NMRD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ergoteles's NMRD Position: Q3 2021 in Review

Ergoteles sold out of Nemaura Medical, Inc. Common Stock (NMRD) in Q3 2021, closing a stake of 28,800 shares — an estimated $298K sold.

Ergoteles first reported a position in NMRD in Q2 2021 and held it in 1 quarter. The position peaked at $298K in Q2 2021. 17 funds tracked by Wall St. Rank hold NMRD as of Q3 2021.

  • Ergoteles reported no remaining Nemaura Medical, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Ergoteles sold 28,800 Nemaura Medical, Inc. Common Stock shares in Q3 2021, an estimated $298K.
  • Ergoteles first reported a position in Nemaura Medical, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • Ergoteles's Nemaura Medical, Inc. Common Stock position peaked at $298K in Q2 2021.
  • 17 funds tracked by Wall St. Rank held Nemaura Medical, Inc. Common Stock as of Q3 2021.

Based on Ergoteles's 13F filing for Q3 2021, filed 15 Nov 2021.